# 21 CFR 314.530 Withdrawal procedures.

21 CFR 314.530 Withdrawal procedures., “Withdrawal procedures”, is a CFR section of [21 CFR Part 314, Subpart H—Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses](https://ontology.bommaritollc.com/id/01a0f094-b5f6-71b1-905f-50e705df47c2); in force.

IRI: <https://ontology.bommaritollc.com/id/01a0f094-c4e6-7632-ad2f-fa2a85282d49>

Within: [Title 21—Food and Drugs](https://ontology.bommaritollc.com/id/01a0f094-b437-7426-9a1d-f0a9f3d3e1aa) › [21 CFR Chapter I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES](https://ontology.bommaritollc.com/id/01a0f094-b455-74b7-9458-ed95d7b5ea58) › [21 CFR Chapter I, Subchapter D—DRUGS FOR HUMAN USE](https://ontology.bommaritollc.com/id/01a0f094-b5e4-722f-99b0-5c1856aef2a9) › [21 CFR Part 314—Applications for FDA approval to market a new drug](https://ontology.bommaritollc.com/id/01a0f094-b84d-7031-b149-cb632d656858) › [21 CFR Part 314, Subpart H—Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses](https://ontology.bommaritollc.com/id/01a0f094-b5f6-71b1-905f-50e705df47c2)

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [cfr-section 21 CFR 314.530](https://ontology.bommaritollc.com/id/01a0f094-c4e7-71d1-af27-c84b6267ff43)
- `eli:cites`:
  - [21 CFR Part 14—Public hearing before a public advisory committee](https://ontology.bommaritollc.com/id/01a0f094-b7e3-7164-897f-83824c3f81b0)
  - [21 CFR Part 15—Public hearing before the Commissioner](https://ontology.bommaritollc.com/id/01a0f094-b7e4-726e-9e3f-f10acf1321db)
  - [21 CFR 10.35 Administrative stay of action.](https://ontology.bommaritollc.com/id/01a0f094-ba6b-74bd-be1f-b91113db3665)
  - [21 CFR 10.55 Separation of functions; ex parte communications.](https://ontology.bommaritollc.com/id/01a0f094-ba6e-770d-b771-beb9a80349dc)
  - [21 CFR 12.32 Request for alternative form of hearing.](https://ontology.bommaritollc.com/id/01a0f094-ba8a-7605-8c72-f43afc42a840)
  - [21 CFR 15.20 Notice of a public hearing before the Commissioner.](https://ontology.bommaritollc.com/id/01a0f094-bb0a-7325-821e-72dbb9d9e95c)
  - [21 CFR 314.510 Approval based on a surrogate endpoint or on an effect on a clinical endpoint other than survival or irreversible morbidity.](https://ontology.bommaritollc.com/id/01a0f094-c4e5-76cd-b2d9-17a3b02eef62)
  - [21 CFR 314.520 Approval with restrictions to assure safe use.](https://ontology.bommaritollc.com/id/01a0f094-c4e5-76cd-b2d9-17b1c73df7d7)
- `prov:wasDerivedFrom`:
  - [evidence from https://www.govinfo.gov/app/details/CFR-2025-title21-vol1](https://ontology.bommaritollc.com/id/01a0f094-c4e6-7632-ad2f-fa2915937f02)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f094-e326-712d-8d11-3e54f2778901)
  - [evidence from https://www.govinfo.gov/app/details/](https://ontology.bommaritollc.com/id/01a0f0d0-c53a-75ae-9804-40aa0cc87d8d)
  - [evidence from https://www.govinfo.gov/link/cfr/21/314?sectionnum=530&year=mostrecent&link-type=details](https://ontology.bommaritollc.com/id/01a10f17-67d4-74f7-8c90-9065478df402)
- `schema:isPartOf`: [21 CFR Part 314, Subpart H—Accelerated Approval of New Drugs for Serious or Life-Threatening Illnesses](https://ontology.bommaritollc.com/id/01a0f094-b5f6-71b1-905f-50e705df47c2)
- `schema:legislationIdentifier`: 21 CFR 314.530
- `schema:legislationJurisdiction`: [United States](https://ontology.bommaritollc.com/id/01a0ed8e-f797-7004-b7f5-bec2695977c0)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [CFR section](https://ontology.bommaritollc.com/vocab/leg/cfrSection)
- `schema:name`: Withdrawal procedures
- `schema:url`: [https://www.govinfo.gov/link/cfr/21/314?sectionnum=530&year=mostrecent&link-type=details](https://www.govinfo.gov/link/cfr/21/314?sectionnum=530&year=mostrecent&link-type=details)
- `skos:prefLabel`: 21 CFR 314.530 Withdrawal procedures.

## Elsewhere

- [Official page](https://www.govinfo.gov/link/cfr/21/314?sectionnum=530&year=mostrecent&link-type=details) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/CFR-2025-title21-vol1) (www.govinfo.gov)
- [Source](https://www.govinfo.gov/app/details/) (www.govinfo.gov)

## Pointing here

- Cited by (1; `eli:cites`):
  - [21 CFR 314.560 Termination of requirements.](https://ontology.bommaritollc.com/id/01a0f094-c4e8-72cc-9503-15d6a6160e88)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0f094-c4e6-7632-ad2f-fa2a85282d49.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0f094-c4e6-7632-ad2f-fa2a85282d49.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0f094-c4e6-7632-ad2f-fa2a85282d49.nt), [HTML](https://ontology.bommaritollc.com/id/01a0f094-c4e6-7632-ad2f-fa2a85282d49)
Cite as: 21 CFR 314.530 Withdrawal procedures.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c4e6-7632-ad2f-fa2a85282d49
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
